Review and prospect of the 33-year development of radiation oncology in China

doi:10.3760/cma.j.issn.1673-422X.2020.01.001

Journal of International Oncology ›› 2020, Vol. 47 ›› Issue (1): 1-9.doi: 10.3760/cma.j.issn.1673-422X.2020.01.001

• Expert Review • Next Articles

Review and prospect of the 33-year development of radiation oncology in China

Huang Wei¹, Zhang Yanke², Zhu Jian³, Li Baosheng¹(), Yu Jinming¹()

1 Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China
2 Department of Radiation Oncology, Zoucheng People's Hospital of Jining, Shandong Province, Zoucheng 273500, China
3 Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China

Received:2019-12-11 Revised:2019-12-14 Online:2020-01-08 Published:2020-03-22
Contact: Li Baosheng,Yu Jinming E-mail:baoshli1963@163.com;sdyujinming@126.com
Supported by:
National Natural Science Foundation of China(81530060);National Natural Science Foundation of China(81773232);National Natural Science Foundation of China(81874224);National Natural Science Foundation of China(81671785);National Key Research and Develop Program of China(2016YFC0105106);Key Research and Development Project of Shandong Province of China(2016GSF201123);Key Research and Development Project of Shandong Province of China(2017CXZC1206);Foundation of Taishan Scholars(ts20120505);Foundation of Taishan Scholars(tsqn201909187);Foundation of Taishan Scholars(tsqn201909140);Academic Promotion Program of Shandong First Medical University and Shandong Academy of Medical Sciences(2019LJ004)

Abstract

Abstract:

Since the establishment of the Chinese Society of Therapeutic Radiation Oncology 33 years ago, radiation oncology has developed rapidly in China. Based on previous survey data, this paper summarizes and reviews the development of radiation oncology in China (excluding Hong Kong, Macao and Taiwan regions) from the perspectives of radiotherapy units, relevant professionals, equipment, technologies and subject development, and looks forward to the future direction, and proposes a new concept—"precision radiotherapy".

Key words: Radiation oncology, China

Huang Wei, Zhang Yanke, Zhu Jian, Li Baosheng, Yu Jinming. Review and prospect of the 33-year development of radiation oncology in China[J]. Journal of International Oncology, 2020, 47(1): 1-9.

Figures/Tables 11

References 43

[1]	“早期放疗史”写作组. 放射治疗学在中国大陆的早期建立和发展(一)[J]. 中华放射肿瘤学杂志, 2006,15(5):351-354.
[2]	谷铣之, 冯宁远, 余耘 . 关于我国放射治疗队伍的组成、设备和技术水平的调查报告[J]. 中国放射肿瘤学, 1989,3(1):41-43.
[3]	殷蔚伯, 田凤华, 谷铣之 . 我国放射治疗人员及设备现状[J]. 中华放射肿瘤学杂志, 1998,7(2):131-133.
[4]	张中柱 . 中国肿瘤放射治疗设备的进步——中国医用加速器发展三十年记[J]. 医疗装备, 2009,22(3):5-8.
[5]	席宁 . 我国肿瘤放射治疗设备及发展方向的探讨[J]. 中国肿瘤临床, 1989,16(3):182-184.
[6]	程广源 . 适形放疗是21世纪放射肿瘤学的发展方向[J]. 立体定向和功能性神经外科杂志, 2003,16(4):240-244.
[7]	刘亚洲, 袁成, 施林心 , 等. 放射性粒子植入技术治疗恶性肿瘤进展[J]. 中国辐射卫生, 2018,27(4):390-394. DOI: 10.13491/j.issn.1004-714x.2018.04.027.
[8]	于金明, 邢力刚 . 中国肿瘤放射治疗学的现状与展望[J]. 肿瘤防治杂志, 2003,10(1):13-16.
[9]	Takahashi S . Conformation radiotherapy. Rotation techniques as applied to radiography and radiotherapy of canner[J]. Acta Radiol Diaqn (Stockh), 1965: Suppl 242: 1+.
[10]	乔延伟 . 肿瘤精确放疗技术发展及应用现状[J]. 中国医疗设备, 2014,29(7):73-76. DOI: 10.3969/j.issn.1674-1633.2014.07.026.
[11]	Brahme A . Optimization of stationary and moving beam radiation therapy techniques[J]. Radiother Oncol, 1988,12(2):129-140. DOI: 10.1016/0167-8140(88)90167-3.
[12]	于金明, 李宝生 . 调强放射治疗的临床应用现状与存在的问题[J]. 中华肿瘤杂志, 2005,27(3):188-190.
[13]	殷蔚伯, 田凤华 . 2001年全国放射治疗人员及设备调查报告[J]. 中华放射肿瘤学杂志, 2002,11(3):145-147.
[14]	殷蔚伯, 余耘, 陈波 , 等. 2006年全国放疗人员及设备调查报告[J]. 中华放射肿瘤学杂志, 2007,16(1):1-5.
[15]	田菲, 徐子海, 王华峰 , 等. 图像引导放射治疗技术的研究现状与发展[J]. 临床医学工程, 2012,19(5):833-835. DOI: 10.3969/j.issn.1674-4659.2012.05.0833.
[16]	董蒙蒙, 雷宏昌, 杨红卫 , 等. 放射治疗技术发展现状[J]. 临床医药文献杂志, 2016,3(35):7092-7093. DOI: 10.16281/j.cnki.jocml.2016.35.126.
[17]	李文辉, 隋军, 秦继勇 , 等. “生物靶区”对肿瘤放射治疗带来的新希望与挑战[J]. 肿瘤预防与治疗, 2009,22(4):352-354.
[18]	穆向魁, 余子豪 . 质子治疗的优越性与发展前景[J]. 中华放射肿瘤学杂志, 2007,16(1):77-78.
[19]	郑秀龙, 金一尊, 沈瑜 . 肿瘤治疗增敏药[M]. 上海: 上海科学技术文献出版社, 1996,28.
[20]	陈纲, 李世拥, 于波 , 等. X线联合胞嘧啶脱氨酶基因对结肠直肠肿瘤细胞的杀伤作用[J]. 中华外科杂志, 2002,40(2):136-138.
[21]	刘新帆, 殷蔚伯, 谷铣之 . 低氧放疗及其临床适应症推断[J]. 中华肿瘤杂志, 1993,15(6):468-469.
[22]	施学辉, 吴根娣, 刘新伟 , 等. 后程加速超分割放射治疗食管癌的长期疗效[J]. 中华放射肿瘤学杂志, 1997,6(1):12-15.
[23]	夏廷毅 . 放疗进展与学科定位暨治疗模式的转变[J]. 中华医学信息导报, 2009,24(24):16-17.
[24]	殷蔚伯, 陈波, 张春立 , 等. 2011年中国大陆地区第六次放疗人员及设备调查[J]. 中华放射肿瘤学杂志, 2011,20(6):453-456. DOI: 10.3760/cma.j.issn.1004-4221.2011.002.
[25]	郞锦义, 王培, 吴大可 , 等. 2015年中国大陆放疗基本情况调查研究[J]. 中华放射肿瘤学杂志, 2016,25(6):541-545. DOI: 10.3760/cma.j.issn.1001-4221.2016.06.001.
[26]	姚乐静, 张鹏 . 我国放射治疗的现状与发展[J]. 中医药管理杂志, 2019,27(1):3-5. DOI: 10.16690/j.cnki.1007-9203.2019.01.003.
[27]	Zhang J, Yang F, Li B , et al. Which is the optimal biologically effective dose of stereotactic body radiotherapy for stage I non-small-cell lung cancer? A meta-analysis[J]. Int J Radiat Oncol Biol Phys, 2011,81(4):e305-e316. DOI: 10.1016/j.ijrobp.2011.04.034.
[28]	Chang JY, Senan S, Paul MA , et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage Ⅰ non-small-cell lung cancer: a pooled analysis of two randomised trials[J]. Lancet Oncol, 2015,16(6):630-637. DOI: 10.1016/S1470-2045(15)70168-3.
[29]	Yu CX . Intensity-modulated arc therapy with dynamic multileaf collimation: an alternative to tomotherapy[J]. Phys Med Biol, 1995,40(9):1435-1449. DOI: 10.1088/0031-9155/40/9/004.
[30]	Otto K . Volumetric modulated arc therapy: IMRT in a single arc[J]. Med Phys, 2008,35(1):310-317. DOI: 10.1118/1.2818738.
[31]	Guckenberger M, Richter A, Krieger T , et al. Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes?[J]. Radiother Oncol, 2009,93(2):259-265. DOI: 10.1016/j.radonc.2009.08.015.
[32]	Mackie TR, Holmes T, Swerdloff S , et al. Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy[J]. Med Phys, 1993,20(6):1709-1719. DOI: 10.1118/1.596958.
[33]	马一栋, 李明焕, 于金明 . 肿瘤精确放疗新技术的比较[J]. 中华肿瘤防治杂志, 2010,17(23):1995-1998.
[34]	陈志深, 范娇娇, 于雷 , 等. 肿瘤术中放疗的研究进展[J]. 中华放射肿瘤学杂志, 2018,27(5):517-521. DOI: 10.3760/cma.j.issn.1004-4221.2018.05.017.
[35]	于金明, 袁双虎 . 肿瘤放疗的发展与挑战[J]. 山东大学学报(医学版), 2011,49(10):48-50, 66.
[36]	黄伟, X.Allen Li, 李宝生 , 等. MRI引导的自适应放疗技术进展[J]. 中华放射肿瘤学杂志, 2017,26(7):819-822. DOI: 10.3760/cma.j.issn.1004-4221.2017.07.021.
[37]	王卫东, 郞锦义 . 基于生命/影像组学和人工智能的精确放射治疗: 思考与展望[J]. 中国肿瘤临床, 2018,45(12):604-608. DOI: 10.3969/j.issn.1000-8179.2018.12.366.
[38]	张珺倩, 张远, 尹勇 , 等. 机器学习在肿瘤放射治疗领域应用进展[J]. 生物医学工程学杂志, 2019,36(5):879-884. DOI: 10.7507/1001-5515.201810051.
[39]	Chen W, Zheng R, Baade PD , et a1. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016,66(2):115-132. DOI: 10.3322/caac.21338.
[40]	郞锦义 . 中国放疗三十年回顾、思考与展望[J]. 肿瘤预防与治疗, 2017,30(1):1-4. DOI: 10.3969/j.issn.1674-0904.2017.01.001.
[41]	朱健, 岳晨曦, 尹勇 , 等. 针对单次大剂量放疗的LQ及BED模型研究进展[J]. 中华放射肿瘤学杂志, 2018,27(9):859-863. DOI: 10.3760/cma.j.issn.1004-4221.2018.09.015.
[42]	祝效鹏, 刘百龙, 历程 , 等. 恶性肿瘤立体定向放疗与免疫治疗研究进展[J]. 中华放射肿瘤学杂志, 2019,28(5):389-393. DOI: 10.3760/cma.j.issn.1004-4221.2019.05.015.
[43]	付庆国, 戴建荣, 朱小东 , 等. 国内外肿瘤放疗QA与QC的相关规范介绍[J]. 中华放射肿瘤学杂志, 2018,27(2):218-221. DOI: 10.3760/cma.j.issn.1004-4221.2018.02.021.

年份	放疗床位数 (万张)	每天治疗人次 (万人次)	年收治患者数 (万例)
2011年	5.687	5.807	56.906
2015年	10.217	7.661	91.934

Review and prospect of the 33-year development of radiation oncology in China

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 11

References 43

Related Articles 5

Recommended Articles

Metrics

Comments

[1]	Duan Shuai, Guo Chenming, Li Huifang, Dilimulati · Aisimutula. Trends in incidence and mortality of female breast cancer in China from 1990 to 2019 and age-period-cohort model analysis [J]. Journal of International Oncology, 2022, 49(10): 586-591.
[2]	Zheng Xin, Chen Xiaopin. Relationship between HPV and oropharyngeal cancer in China [J]. Journal of International Oncology, 2020, 47(3): 164-168.
[3]	LIU Jing, ZHANG Juan, 欧Yang-Tao , LI Jin-Feng, WANG Tian-Feng, FAN Zhao-Qing, FAN Tie, LIN Ben-Yao, JIE Yun-Tao. Risk of cancer other than breast or ovarian in Chinese Han women with BRCA1/2 mutations [J]. Journal of International Oncology, 2013, 40(5): 389-392.
[4]	ZHEN Tian-Min, MA Xia, LI Jing-Li, HAN Zhi-Yan, YANG Wen-Yan, ZHANG Jing-Jing, SUN Na. Comparative analysis of Chinese oncology papers included by CBM and SCI in 2012 [J]. Journal of International Oncology, 2013, 40(12): 952-954.
[5]	ZHEN Tian-Min, MA Xia, YANG Wen-Yan, ZHANG Jing-Jing, SUN Na. Analysis of Chinese oncology papers included by SCI in 2012 [J]. Journal of International Oncology, 2013, 40(12): 947-951.